Glyburide-Metformin Hydrochloride 2.5 mg/1 (Glyburide-Metformin Hydrochloride TABLET) 2.5 mg/1

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve glycemic control.

Strength

2.5 mg/1

Pack Size

1000 TABLET in 1 BOTTLE (23155-234-10)

Manufacturer / TM Owner

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets are typically used to help manage type 2 diabetes. The combination of glyburide and metformin works to lower blood sugar levels, supporting overall diabetes management. This medication is often prescribed when diet and exercise alone are not sufficient to control blood glucose.

Side Effects

Common effects of Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets may include hypoglycemia, nausea, and diarrhea. Some users may also experience weight changes or gastrointestinal discomfort. Individual responses can vary, and it's important to monitor for any adverse reactions.

Precautions & Warnings

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets should be handled with care, especially for those with kidney or liver issues. Regular blood sugar monitoring is advised. Always follow the guidance of a healthcare provider regarding usage and monitoring.

Avoid Interactions

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets may interact with certain medications, including other diabetes drugs, beta-blockers, and alcohol. It's important to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets are used to manage type 2 diabetes by helping to lower blood sugar levels.

Glyburide-Metformin Hydrochloride 2.5 mg/1 tablets are taken orally, typically as directed by a healthcare provider.

Common side effects may include hypoglycemia, nausea, and diarrhea. Individual responses can vary.

Glyburide-Metformin Hydrochloride 2.5 mg/1 may interact with other medications, so it's important to consult a healthcare provider.

Individuals with certain kidney or liver conditions should exercise caution and consult a healthcare provider before taking this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.